Imaging of Histiocytosis in the Era of Genomic Medicine.

Abstract

Histiocytosis describes a group of diseases that have long been considered enigmatic in the history of medicine. Recently, novel genomic analyses have identified somatic oncogenic driver mutations responsible for the pathogenesis of these entities. These discoveries have led to the recharacterization of histiocytoses as neoplastic diseases and have opened a new era of precision medicine approaches for treatment. The histiocytic disorders demonstrate a variety of imaging manifestations involving multiple organ systems, and radiologists play a major role in diagnosis and monitoring. An up-to-date knowledge of the novel genomic discoveries and their implications is essential for radiologists to understand the new approaches to treating histiocytic disorders and to contribute as key members of the multidisciplinary treatment team. This article provides a cutting-edge review of the novel concepts in histiocytosis, with a focus on recent genomic discoveries and precision medicine approaches to treating the disease, and describes imaging manifestations with correlative histologic and genomic findings, with an emphasis on adult-onset cases and uncommon subtypes. ©RSNA, 2018.

• Authors: Hyesun Park, Mizuki Nishino, Jason L Hornick, Eric D Jacobsen
• Journal: Radiographics : a review publication of the Radiological Society of North America, Inc (Radiographics) 2019 Jan-Feb Vol. 39 Issue 1 Pg. 95-114 ISSN: 1527-1323 [Electronic] United States
• PMID: 30500304 (Publication Type: Journal Article, Review)

Chemical References

• BRAF protein, human
• Proto-Oncogene Proteins B-raf

Topics

• Female
• Genomics
• Histiocytosis (diagnostic imaging, genetics, pathology, therapy)
• Humans
• Male
• Mutation
• Precision Medicine
• Proto-Oncogene Proteins B-raf (antagonists & inhibitors)